Scientists work toward a Chlamydia vaccine

Jul 25, 2006

U.S. scientists studying how the immune system responds to genital tract infections are using a mouse model to track immunity against Chlamydia.

The Harvard Medical School researchers say their findings might hasten the development of vaccines for Chlamydia -- the most common cause of bacterial sexually transmitted disease in the United States.

"Right now Chlamydia is sensitive to treatment with antibiotics," said Michael Starnbach, associate professor of microbiology and molecular genetics. "But the problem is that many people have 'silent' infections that remain untreated,

"These undiagnosed infections, over time, lead to complications like tubal pregnancy and infertility. The goal would be to vaccinate young people to keep them from suffering from undiagnosed infection and the bad outcomes associated with it."

The study -- funded by the National Institutes of Health -- appears in the early online edition of the Proceedings of the National Academy of Sciences.

Copyright 2006 by United Press International

Explore further: Too much iced tea caused US man's kidney problems

Related Stories

Molecular ruler sets bacterial needle length

Mar 16, 2015

When a salmonella bacterium attacks a cell, it uses a nanoscopic needle to inject it with proteins to aid the infection. If the needle is too short, the cell won't be infected. Too long, and the needle breaks. ...

The mathematics of chlamydia's spread

Feb 03, 2014

(Phys.org) —It sounds an unlikely pairing: using maths to combat the spread of a sexually transmitted disease that can lead to infertility, but a group of mathematicians has delivered a solution that enables ...

Seniors' sex lives are up -- and so are STD cases

May 17, 2011

Across the nation, and especially in communities that attract a lot of older Americans, the free-love generation is continuing to enjoy an active - if not always healthy - sex life.

Recommended for you

Outcomes no worse for macrolide-resistant pneumonia

14 minutes ago

(HealthDay)—For patients with Streptococcus pneumoniae pneumonia, macrolide-resistance is not associated with worse outcomes, according to a study published online March 25 in the American Journal of Respir ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.